CIBC Private Wealth Group
JANX icon

CIBC Private Wealth Group’s Janux Therapeutics JANX Stock Holding History

CIBC Private Wealth Group’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.36K Hold
171
– – ﹤0.01% 2772
2025
Q3 		$4.18K Hold
171
– – ﹤0.01% 2605
2025
Q2 		$3.95K Hold
171
– – ﹤0.01% 2501
2025
Q1 		$4.07K Buy
+171
New +$6.45K ﹤0.01% 2505

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIBC Private Wealth Group's JANX Position: Q4 2025 in Review

CIBC Private Wealth Group held its Janux Therapeutics (JANX) position steady in Q4 2025 at 171 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

CIBC Private Wealth Group first reported a position in JANX in Q1 2025 and has held it in 4 quarters since. The position peaked at $4.18K in Q3 2025. 176 funds tracked by Wall St. Rank hold JANX as of Q4 2025.

  • CIBC Private Wealth Group held 171 shares of Janux Therapeutics worth $2.36K as of Q4 2025.
  • CIBC Private Wealth Group left its Janux Therapeutics share count unchanged in Q4 2025.
  • Janux Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2772 holding.
  • CIBC Private Wealth Group first reported a position in Janux Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • CIBC Private Wealth Group's Janux Therapeutics position peaked at $4.18K in Q3 2025.
  • 176 funds tracked by Wall St. Rank held Janux Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.